Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Disclaimer: This content is for informational purposes only and is not intended as financial advice.
Upcoming Catalyst:
Date: 3Q 2024
Details: Anticipating a potential pre-run-up leading to the data release.
Investment Overview (Dated 03/05/2024):
Relative Volume: 1.51
Shares Float: 97.27 million
Short Float: 13.16%
Key Technical Levels:
Potential Gap Fill: Above $1.00 needs to break for confirmation.
Resistance Levels: Look for resistance at $1.40, $1.80, and $2.05. Breaking above these levels could indicate an upward trend. Taking partial profits at these points might secure gains.
Trading Strategy:
Take Profit (TP): Target a profit at $2.20 to achieve a full gap fill.
Stop Loss (SL): Set a stop loss below $0.80 to minimize potential losses.
Chart Analysis:
Refer to the accompanying chart for a comprehensive analysis of price movements and trend lines.
Trading Caution:
Trade with careful consideration of market conditions and personal risk tolerance.
Conduct thorough research or consult a financial advisor before making investment decisions.